Phillip W. Berman
Affiliations: | Biomolecular Engineering | University of California, Santa Cruz, Santa Cruz, CA, United States |
Area:
Drug development, vaccines, AIDS, monoclonal antibody therapeutics, immunology, molecular cell/biology, recombinant protein productionWebsite:
http://www.soe.ucsc.edu/people/pwbGoogle:
"Phillip Wayne Berman"Bio:
http://www.chemistry.ucsc.edu/faculty/singleton.php?&singleton=true&cruz_id=pwb
http://dartmed.dartmouth.edu/fall11/html/alumni_album/
https://pwb.soe.ucsc.edu/biobibliography
Mean distance: 9.07 | S | N | B | C | P |
Cross-listing: ID Tree
Parents
Sign in to add mentor| Henry A. Harbury | grad student | 1977 | Dartmouth Medical School | |
| (Immunochemistry of horse cytochrome c̲ : identification of antigenic determinants through studies of reconstituted and hybrid preparations) | ||||
| Steve F. Heinemann | post-doc | 1977-1981 | Salk Institute (Neurotree) | |
| Herbert W. Boyer | post-doc | 1981-1982 | UCSF | |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Li SW, Wright M, Healey JF, et al. (2020) Gene editing in CHO cells to prevent proteolysis and enhance glycosylation: Production of HIV envelope proteins as vaccine immunogens. Plos One. 15: e0233866 |
| Hutchinson JM, Mesa KA, Alexander DL, et al. (2019) Unusual Cysteine Content in V1 Region of gp120 From an Elite Suppressor That Produces Broadly Neutralizing Antibodies. Frontiers in Immunology. 10: 1021 |
| Li S, Yu B, Byrne G, et al. (2019) Identification and CRISPR/Cas9 Knockout of the Endogenous C1s Protease in CHO Cells Eliminates Aberrant Proteolysis of Recombinantly Expressed Proteins. Biotechnology and Bioengineering |
| Mesa KA, Yu B, Wrin T, et al. (2019) Ancestral sequences from an elite neutralizer proximal to the development of neutralization resistance as a potential source of HIV vaccine immunogens. Plos One. 14: e0213409 |
| O'Rourke SM, Yu B, Morales JF, et al. (2018) Production of a recombinant monoclonal antibody to Herpes Simplex Virus glycoprotein D for immunoaffinity purification of tagged proteins. Journal of Immunological Methods |
| Doran RC, Yu B, Wright M, et al. (2018) Development of a Stable MGAT1 CHO Cell Line to Produce Clade C gp120 With Improved Binding to Broadly Neutralizing Antibodies. Frontiers in Immunology. 9: 2313 |
| Byrne G, O'Rourke SM, Alexander DL, et al. (2018) CRISPR/Cas9 gene editing for the creation of an MGAT1-deficient CHO cell line to control HIV-1 vaccine glycosylation. Plos Biology. 16: e2005817 |
| O'Rourke SM, Byrne G, Tatsuno G, et al. (2018) Robotic selection for the rapid development of stable CHO cell lines for HIV vaccine production. Plos One. 13: e0197656 |
| Doran RC, Tatsuno GP, O'Rourke SM, et al. (2018) Glycan modifications to the gp120 immunogens used in the RV144 vaccine trial improve binding to broadly neutralizing antibodies. Plos One. 13: e0196370 |
| Yates NL, deCamp AC, Korber BT, et al. (2018) HIV-1 Envelope Glycoproteins from Diverse Clades Differentiate Antibody Responses and Durability among Vaccinees. Journal of Virology |